S21 Natural products: Bridging ancient medicine and synthetic biology
Tuesday, January 13, 2015: 11:30 AM
California Ballroom AB
Esther Schmitt, Natural Products Unit, Novartis, Basel, Switzerland
Natural products continue to be a source of innovation in the pharmaceutical industry. At Novartis, natural products are screened in disease relevant and phenotypic assays related to many different disease areas. This talk will focus on recent results with natural products in drug discovery projects and target identification activities. The impact of the concepts and tools of synthetic biology on natural product based drug discovery and development will also be discussed.